The ability to predict blood sugars ahead of time is new, and doctors have a hard time believing it can be done. After we explain it, doctors go from disbelief to saying – this is a really clever idea.
Melbourne, Australia (PRWEB) February 12, 2014
ManageBGL prevented a tragedy when it predicted an eight-year old girl with Type 1 (Insulin-dependent) diabetes would have a dangerously low blood sugar (hypoglycaemia or ‘hypo’) during a school swimming lesson. At work, her father noticed the pending low remotely, called the school and asked them to urgently pull her out. The receptionist (whose husband is also diabetic), ran to deliver the message. On pulling the girl out, her blood test was 30 mg (1.7 mmol) – dangerously low and close to unconsciousness – and she was not even aware of it.
Without the prediction, the situation in the pool could have been dire, even fatal.
ManageBGL is used by over a thousand diabetics worldwide - to avert daily situations just like this, as well as making sleeping far safer.
Diabetes affects 382 million people worldwide. ManageBGL is for people with both Type 1 (Insulin-dependent, IDDM) and Type 2 diabetes and their carers, and predicts dangerous low blood sugars up to 8 hours ahead. The person enters blood sugar and carbohydrates, and ManageBGL calculates the insulin dose, and then predicts the complex curve the blood sugar will follow.
ManageBGL is the brain-child of Simon Carter, founder and long-term Type 1 diabetic, father of a diabetic child and software entrepreneur.
“The ability to predict blood sugars ahead of time is new, and doctors have a hard time believing it can be done. After we explain it, doctors go from disbelief to saying – this is a really clever idea” says Simon. “Whether it is at school, or predicting dangerous low blood sugars overnight, ManageBGL reduces the risks and constant stresses of having diabetes.”
ManageBGL also seeks to reduce the massive costs of intensive insulin therapy. By providing the same dose calculations and tracking of insulin remaining as an insulin pump, it saves $5000 and $1000/year in pump consumables. The patient injects normally with syringes or insulin pens. It also offers blood sugar history comparable to a Continuous Glucose Monitor, saving $5000 and $1000/year.
ManageBGL is now crowd-funding on Indiegogo.com to develop medical-grade native apps to run offline on iPhone and Android smart phones and tablets. This will allow it to work on planes, at sea, and in any area where cellular coverage is limited or too expensive, such as when travelling.
ManageBGL is offered worldwide, with a 14-day free trial period, then USD 100/year.
For more information or to arrange an interview, please contact ManageBGL.
ManageBGL.com is a web app designed to run in any browser on Windows and Mac PCs, iPads, iPods, and iPhone and Android smart phones.
ManageBGL.com was founded in 2012 by the founders of DataMystic, a successful data mining, data conversion and software development company founded in 2001. ManageBGL.com is the world leader in diabetes data modeling and integration, and the world leader in prediction of future blood sugar levels.